Baldomero Arianne K, Kunisaki Ken M, Bangerter Ann, Nelson David B, Wendt Chris H, Fortis Spyridon, Hagedorn Hildi, Dudley R Adams
Pulmonary, Allergy, Critical Care, and Sleep Medicine, Minneapolis VA Health Care System, Minneapolis, Minnesota, United States.
Pulmonary, Allergy, Critical Care, and Sleep Medicine, University of Minnesota, Minneapolis, Minnesota, United States.
Chronic Obstr Pulm Dis. 2022 Oct 26;9(4):538-548. doi: 10.15326/jcopdf.2022.0303.
Many patients with suspected chronic obstructive pulmonary disease (COPD) do not undergo spirometry to confirm the diagnosis. Underutilization is often attributed to barriers to accessing spirometry.
Our objective wasto identify factors associated with spirometry underutilization for patients who are less likely to face access barriers related to travel, insurance, and availability of spirometry.
A retrospective analysis was conducted of patients enrolled in the Veterans Health Administration and living in urban areas with a new diagnosis of COPD between 2012 to 2015, reducing out-of-pocket cost and travel barriers, respectively. We included only patients whose primary care clinic was located in an academically affiliated tertiary level facility with spirometry available. We used logistic regression to estimate associations between patient characteristics and receipt of spirometry within 2 years before or after COPD diagnosis.
Of 24,300 patients, 59.7% had spirometry. Compared to patients <55 years, patients 75-84 years had an adjusted odds ratio (aOR) of undergoing spirometry of 0.80 (95% confidence interval [CI]:0.72-0.90), while patients ≥85 years had an aOR of 0.47 (95%CI: 0.40-0.54). Compared to patients with a Charlson Comorbidity Index (CCI) ≥3, patients with a CCI of 0 had an aOR of 0.60 (95%CI:0.54-0.67). Patients who had not seen a pulmonary specialist had lower odds of receiving spirometry (aOR 0.38 [95%CI:0.35-0.41]).
Spirometry underutilization persists among patients who are less likely to have access barriers related to travel, insurance, and availability of spirometry. Spirometry underutilization is associated with older age, not having received pulmonary care, and having fewer comorbidities. COPD care quality initiatives will need to address these factors.
许多疑似慢性阻塞性肺疾病(COPD)的患者未进行肺功能测定以确诊。未充分利用肺功能测定通常归因于进行肺功能测定存在障碍。
我们的目的是确定在不太可能面临与出行、保险和肺功能测定可用性相关的获取障碍的患者中,与肺功能测定未充分利用相关的因素。
对2012年至2015年间在退伍军人健康管理局登记且居住在城市地区、新诊断为COPD的患者进行回顾性分析,分别降低了自付费用和出行障碍。我们仅纳入其初级保健诊所位于配备肺功能测定设备的学术附属三级医疗机构的患者。我们使用逻辑回归来估计患者特征与COPD诊断前后2年内接受肺功能测定之间的关联。
在24300名患者中,59.7%进行了肺功能测定。与55岁以下的患者相比,75 - 84岁的患者进行肺功能测定的调整优势比(aOR)为0.80(95%置信区间[CI]:0.72 - 0.90),而85岁及以上的患者aOR为0.47(95%CI:0.40 - 0.54)。与Charlson合并症指数(CCI)≥3的患者相比,CCI为0的患者aOR为0.60(95%CI:0.54 - 0.67)。未看过肺科专科医生的患者接受肺功能测定的几率较低(aOR 0.38 [9